DK1858917T3 - Varicella-zoster-virus-vaccine - Google Patents

Varicella-zoster-virus-vaccine Download PDF

Info

Publication number
DK1858917T3
DK1858917T3 DK06707446.8T DK06707446T DK1858917T3 DK 1858917 T3 DK1858917 T3 DK 1858917T3 DK 06707446 T DK06707446 T DK 06707446T DK 1858917 T3 DK1858917 T3 DK 1858917T3
Authority
DK
Denmark
Prior art keywords
varicella
virus vaccine
zoster virus
zoster
vaccine
Prior art date
Application number
DK06707446.8T
Other languages
English (en)
Inventor
Emmanuel J Glaxosmithkline Biologicals Sa Hanon
Jean Glaxosmithkline Biologicals Sa Stephenne
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1858917(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of DK1858917T3 publication Critical patent/DK1858917T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK06707446.8T 2005-03-03 2006-03-01 Varicella-zoster-virus-vaccine DK1858917T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0504436.7A GB0504436D0 (en) 2005-03-03 2005-03-03 Vaccine
PCT/EP2006/002070 WO2006094756A2 (en) 2005-03-03 2006-03-01 Varicella zoster virus vaccine

Publications (1)

Publication Number Publication Date
DK1858917T3 true DK1858917T3 (da) 2015-02-02

Family

ID=34430592

Family Applications (4)

Application Number Title Priority Date Filing Date
DK10188215.7T DK2301955T3 (da) 2005-03-03 2006-03-01 Varicella-zoster virus vaccine
DK06707446.8T DK1858917T3 (da) 2005-03-03 2006-03-01 Varicella-zoster-virus-vaccine
DK10188256.1T DK2281831T3 (da) 2005-03-03 2006-03-01 Varicella-zoster virus vaccine
DK10188214.0T DK2281830T3 (da) 2005-03-03 2006-03-01 Varicella zoster-virusvaccine.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10188215.7T DK2301955T3 (da) 2005-03-03 2006-03-01 Varicella-zoster virus vaccine

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK10188256.1T DK2281831T3 (da) 2005-03-03 2006-03-01 Varicella-zoster virus vaccine
DK10188214.0T DK2281830T3 (da) 2005-03-03 2006-03-01 Varicella zoster-virusvaccine.

Country Status (35)

Country Link
US (3) US20080171079A1 (da)
EP (4) EP2281830B1 (da)
JP (2) JP5420842B2 (da)
KR (2) KR20140006115A (da)
CN (2) CN103028113B (da)
AR (2) AR052498A1 (da)
AU (1) AU2006222225B2 (da)
BR (1) BRPI0607840B1 (da)
CA (2) CA2882255C (da)
CY (5) CY1116108T1 (da)
DK (4) DK2301955T3 (da)
EA (1) EA011884B1 (da)
ES (4) ES2675054T3 (da)
GB (1) GB0504436D0 (da)
HK (1) HK1111427A1 (da)
HR (4) HRP20150142T1 (da)
HU (4) HUE032544T2 (da)
IL (1) IL185442A (da)
LT (4) LT2281830T (da)
LU (1) LUC00087I2 (da)
MA (1) MA29714B1 (da)
MX (2) MX2007010626A (da)
MY (1) MY148464A (da)
NL (1) NL300951I2 (da)
NO (2) NO341841B1 (da)
NZ (1) NZ561075A (da)
PE (2) PE20100658A1 (da)
PL (4) PL2281831T3 (da)
PT (4) PT2301955T (da)
SI (4) SI2281830T1 (da)
TR (2) TR201809393T4 (da)
TW (1) TWI403517B (da)
UA (1) UA94900C2 (da)
WO (1) WO2006094756A2 (da)
ZA (1) ZA200707144B (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
RU2010105858A (ru) * 2007-07-19 2011-08-27 Новавакс, Инк. (Us) Вирусоподобные частицы (vlp) вируса varicella zoster и антигены
FR2952825B1 (fr) 2009-11-24 2012-05-25 Goaster Jacqueline Le Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2
WO2012006369A2 (en) 2010-07-06 2012-01-12 Novartis Ag Immunisation of large mammals with low doses of rna
HUE047796T2 (hu) 2010-07-06 2020-05-28 Glaxosmithkline Biologicals Sa RNS bevitele több immunútvonal bekapcsolására
ES2557382T3 (es) 2010-07-06 2016-01-25 Glaxosmithkline Biologicals Sa Liposomas con lípidos que tienen un valor de pKa ventajoso para el suministro de ARN
UA112970C2 (uk) * 2010-08-05 2016-11-25 Мерк Шарп Енд Доме Корп. Інактивований вірус вітряної віспи, спосіб його одержання і застосування
DK4066855T3 (da) 2010-08-31 2023-02-20 Glaxosmithkline Biologicals Sa Pegylerede liposomer til forsyning af RNA, der koder for immunogen
TR201903651T4 (tr) 2010-10-11 2019-04-22 Glaxosmithkline Biologicals Sa Antijen uygulama platformları.
US11896636B2 (en) 2011-07-06 2024-02-13 Glaxosmithkline Biologicals Sa Immunogenic combination compositions and uses thereof
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
CN105530953A (zh) * 2013-10-03 2016-04-27 日东电工株式会社 注射疫苗组合物
JP6499420B2 (ja) * 2014-11-13 2019-04-10 公益財団法人ヒューマンサイエンス振興財団 ワクチン及び感染防御キット
BE1022523B1 (fr) * 2014-12-18 2016-05-20 Glaxosmithkline Biologicals Sa Vaccination
WO2016096968A1 (en) * 2014-12-18 2016-06-23 Glaxosmithkline Biologicals S.A. Vaccination
CA3002912A1 (en) * 2015-10-22 2017-04-27 Modernatx, Inc. Nucleic acid vaccines for varicella zoster virus (vzv)
EP4349405A3 (en) 2015-10-22 2024-06-19 ModernaTX, Inc. Respiratory virus vaccines
JP6900385B2 (ja) 2015-11-06 2021-07-07 アジュバンス・テクノロジーズ・インコーポレーテッド トリテルペンサポニン類似物
WO2018089851A2 (en) 2016-11-11 2018-05-17 Modernatx, Inc. Influenza vaccine
KR102028463B1 (ko) 2016-11-25 2019-10-04 재단법인 목암생명과학연구소 바리셀라 조스터 바이러스 백신
WO2018097642A1 (ko) * 2016-11-25 2018-05-31 재단법인 목암생명과학연구소 바리셀라 조스터 바이러스 백신
CN107022559A (zh) * 2016-12-08 2017-08-08 长春祈健生物制品有限公司 一种水痘‑带状疱疹病毒糖蛋白e胞外区蛋白的制备方法
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
PE20191547A1 (es) * 2016-12-26 2019-10-24 Mogam Inst Biomedical Res Composicion de vacuna contra el herpes zoster
CN108727503A (zh) * 2017-04-18 2018-11-02 武汉博沃生物科技有限公司 VZV重组gE-鞭毛素融合蛋白及其制备方法和应用
US20200164065A1 (en) * 2017-04-25 2020-05-28 Adjuvance Technologies, Inc. Triterpene saponin analogues
CA3061205A1 (en) * 2017-04-25 2018-11-01 Adjuvance Technologies, Inc. Triterpene saponin analogues
EP3615061A1 (en) 2017-04-28 2020-03-04 GlaxoSmithKline Biologicals S.A. Vaccination
GB201707700D0 (en) 2017-05-12 2017-06-28 Glaxosmithkline Biologicals Sa Dried composition
JP7291633B2 (ja) 2017-05-30 2023-06-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム アジュバントを製造する方法
CA3075822A1 (en) 2017-10-16 2019-04-25 Adjuvance Technologies, Inc. Triterpene saponin analogues
CA3083078A1 (en) 2017-12-01 2019-06-06 Glaxosmithkline Biologicals Sa Saponin purification
CN108315344A (zh) * 2018-02-14 2018-07-24 武汉博沃生物科技有限公司 Vzv糖蛋白e基因表达载体及其重组酵母菌株与应用
KR102337922B1 (ko) 2018-04-19 2021-12-09 가천대학교 산학협력단 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물
KR20190121956A (ko) 2018-04-19 2019-10-29 가천대학교 산학협력단 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물
AU2019272184B2 (en) * 2018-05-23 2022-01-27 Mogam Institute For Biomedical Research Antigen variant of varicella zoster virus and use thereof
MX2021001479A (es) 2018-08-07 2021-04-28 Glaxosmithkline Biologicals Sa Novedosos procesos y vacunas.
CN108992667A (zh) * 2018-08-09 2018-12-14 安徽智飞龙科马生物制药有限公司 一种带状疱疹疫苗及其制备方法、应用
KR102270048B1 (ko) * 2020-07-10 2021-06-28 주식회사 녹십자 바리셀라 조스터 바이러스 표면 단백질 항원의 생산 방법
CA3114658A1 (en) * 2018-09-27 2020-04-02 Bravovax Co., Ltd Immune composition, preparation method therefor and use thereof
US20220339282A1 (en) 2018-11-29 2022-10-27 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
CN109602901B (zh) * 2019-01-08 2022-05-27 成都迈科康生物科技有限公司 一种带状疱疹病毒疫苗及其制备方法和应用
WO2020190750A1 (en) 2019-03-15 2020-09-24 Modernatx, Inc. Hiv rna vaccines
US20220235095A1 (en) 2019-06-05 2022-07-28 Glaxosmithkline Biologicals Sa Saponin purification
CN112142828B (zh) * 2019-06-28 2022-02-01 怡道生物科技(苏州)有限公司 一种gE基因及表达该基因的载体
TW202128216A (zh) * 2019-12-13 2021-08-01 大陸商遠大賽威信生命科學（南京）有限公司 免疫刺激組合物及其用途
WO2021172971A1 (ko) * 2020-02-28 2021-09-02 (주)셀트리온 수두 대상포진 바이러스 융합 단백질 및 이를 포함하는 면역원성 조성물
CA3188708A1 (en) 2020-08-07 2022-02-10 Access To Advanced Health Institute Purified saponins and chromatographic process for purification of same
KR102660479B1 (ko) * 2020-09-11 2024-04-25 주식회사 유바이오로직스 수두 또는 대상포진 백신 조성물 및 이를 이용하는 방법
RU2750818C1 (ru) * 2020-11-19 2021-07-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова Вирусный штамм для получения аттенуированной живой культуральной вакцины для профилактики и лечения опоясывающего герпеса для взрослого населения
WO2023056912A1 (en) * 2021-10-08 2023-04-13 Suzhou Abogen Biosciences Co., Ltd. Nucleic acid vaccines for vzv
WO2023064612A2 (en) 2021-10-15 2023-04-20 BioNTech SE Pharmaceutical compositions for delivery of viral antigens and related methods
CN118401544A (zh) 2021-11-24 2024-07-26 旗舰创业创新六公司 水痘-带状疱疹病毒免疫原组合物及其用途
CN116350770B (zh) * 2021-12-28 2024-07-12 成都迈科康生物科技有限公司 一种带状疱疹疫苗制剂及其制备方法
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production
CN116655748B (zh) * 2023-02-28 2024-07-26 易慧生物技术(上海)有限公司 一种截短型水痘-带状疱疹病毒gE蛋白及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5341202B2 (da) 1974-03-12 1978-11-01
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4769239A (en) 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
CY1933A (en) 1989-06-27 1990-06-22 Smithkline Biolog Novel compounds
EP0468520A3 (en) 1990-07-27 1992-07-01 Mitsui Toatsu Chemicals, Inc. Immunostimulatory remedies containing palindromic dna sequences
JP3723231B2 (ja) 1991-12-23 2005-12-07 ディミナコ アクチェンゲゼルシャフト アジュバント
ES2143716T3 (es) 1992-06-25 2000-05-16 Smithkline Beecham Biolog Composicion de vacuna que contiene adyuvantes.
DE69331322T3 (de) * 1992-07-17 2009-10-22 Merck & Co., Inc. Methode zur verhinderung von zoster und linderung der mit varicellea verbundenen postherpetischen neuralgie
SG48309A1 (en) 1993-03-23 1998-04-17 Smithkline Beecham Biolog Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
US5976552A (en) * 1995-04-28 1999-11-02 Protein Sciences Corporation Virus vaccines
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
EP1167377B2 (en) 1994-07-15 2012-08-08 University of Iowa Research Foundation Immunomodulatory oligonucleotides
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
ATE279517T1 (de) * 1995-03-23 2004-10-15 Immunex Corp Il-17 receptor
US6846489B1 (en) 1995-04-25 2005-01-25 Smithkline Beecham Biologicals S.A. Vaccines containing a saponin and a sterol
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
KR0177323B1 (ko) * 1996-02-16 1999-04-01 성재갑 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법
TR199902437T2 (xx) 1997-04-01 2000-01-21 Corixa Corporation Monofosforil lipid A'ya ait sulu im�nolojik adjuvant terkipleri.
DE69815692T2 (de) 1997-09-05 2004-04-29 Glaxosmithkline Biologicals S.A. Öl in wasser emulsionen mit saponinen
GB9718901D0 (en) 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
NZ525320A (en) * 2000-10-18 2004-10-29 Glaxosmithkline Biolog S Combinations of immunostimulatory oligonucleotides (CpG), saponin and optionally lipopolysaccharides as potent vaccine adjuvants
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
WO2006094756A2 (en) 2006-09-14
CN103028113A (zh) 2013-04-10
PT2281830T (pt) 2017-02-24
PL2281830T3 (pl) 2017-06-30
LTPA2018012I1 (lt) 2018-11-12
PL2281831T3 (pl) 2018-08-31
HRP20180989T1 (hr) 2018-08-10
US20080171079A1 (en) 2008-07-17
JP2008531637A (ja) 2008-08-14
NO341841B1 (no) 2018-02-05
KR20070110413A (ko) 2007-11-16
ZA200707144B (en) 2009-11-25
EP1858917B8 (en) 2015-05-06
US20110045059A1 (en) 2011-02-24
CY1120347T1 (el) 2018-12-12
SI2301955T1 (en) 2018-07-31
HUS1800038I1 (hu) 2018-10-29
HRP20170081T1 (hr) 2017-03-24
PT2301955T (pt) 2018-06-18
US7939084B1 (en) 2011-05-10
PT1858917E (pt) 2015-02-24
CY1116108T1 (el) 2017-02-08
DK2301955T3 (da) 2018-06-14
HK1111427A1 (en) 2008-08-08
EP2281830A2 (en) 2011-02-09
TWI403517B (zh) 2013-08-01
CA2600905A1 (en) 2006-09-14
EP2281830B1 (en) 2016-12-21
KR101357204B1 (ko) 2014-02-06
EP2301955B1 (en) 2018-04-18
ES2675055T3 (es) 2018-07-06
CA2882255C (en) 2018-03-27
PL2301955T3 (pl) 2018-08-31
EP2301955A2 (en) 2011-03-30
SI1858917T1 (sl) 2015-03-31
DK2281831T3 (da) 2018-06-14
CN101189254B (zh) 2013-05-22
JP5840167B2 (ja) 2016-01-06
NO2018033I1 (no) 2018-09-20
NZ561075A (en) 2009-06-26
MX2007010626A (es) 2007-10-16
BRPI0607840A2 (pt) 2009-06-13
AU2006222225B2 (en) 2012-08-16
CY1121211T1 (el) 2020-05-29
CN103028113B (zh) 2015-05-20
EP2281831A2 (en) 2011-02-09
KR20140006115A (ko) 2014-01-15
DK2281830T3 (da) 2017-03-20
LUC00087I2 (da) 2018-11-26
AR052498A1 (es) 2007-03-21
PL1858917T3 (pl) 2015-05-29
MA29714B1 (fr) 2008-09-01
SI2281831T1 (en) 2018-07-31
SI2281830T1 (sl) 2017-03-31
AR107285A2 (es) 2018-04-18
LTC2281831I2 (lt) 2020-08-25
EA011884B1 (ru) 2009-06-30
EP1858917B1 (en) 2014-12-24
CY2018025I2 (el) 2018-12-12
EP2301955A3 (en) 2011-11-16
HRP20180988T1 (hr) 2018-08-10
GB0504436D0 (en) 2005-04-06
ES2618037T3 (es) 2017-06-20
EP2281830A3 (en) 2012-01-25
LT2281830T (lt) 2017-02-10
TR201809393T4 (tr) 2018-07-23
EP1858917A2 (en) 2007-11-28
CY2018025I1 (el) 2018-12-12
MX346865B (es) 2017-04-04
PE20100658A1 (es) 2010-10-23
US20110104260A1 (en) 2011-05-05
CN101189254A (zh) 2008-05-28
LT2301955T (lt) 2018-07-10
ES2532803T3 (es) 2015-03-31
NL300951I2 (nl) 2020-08-31
HUE038467T2 (hu) 2018-10-29
CA2600905C (en) 2015-05-05
CA2882255A1 (en) 2006-09-14
BRPI0607840B1 (pt) 2021-06-29
PT2281831T (pt) 2018-06-15
EA200701632A1 (ru) 2008-02-28
HUE038468T2 (hu) 2018-10-29
EP2281831B1 (en) 2018-04-18
CY1118629T1 (el) 2017-07-12
NL300951I1 (nl) 2018-09-26
EP2281831A3 (en) 2011-11-16
HRP20150142T1 (hr) 2015-05-22
TW200643028A (en) 2006-12-16
WO2006094756A3 (en) 2007-02-15
PE20061287A1 (es) 2006-12-07
NO20074392L (no) 2007-11-27
TR201809397T4 (tr) 2018-07-23
UA94900C2 (uk) 2011-06-25
AU2006222225A1 (en) 2006-09-14
IL185442A0 (en) 2008-01-06
JP2013144710A (ja) 2013-07-25
MY148464A (en) 2013-04-30
JP5420842B2 (ja) 2014-02-19
IL185442A (en) 2013-07-31
LT2281831T (lt) 2018-07-10
HUE032544T2 (en) 2017-10-30
ES2675054T3 (es) 2018-07-06

Similar Documents

Publication Publication Date Title
DK1858917T3 (da) Varicella-zoster-virus-vaccine
DK1968631T3 (da) Vaccine
DK1926496T3 (da) PCV-2-vaccine
ATE462445T1 (de) Prrs-impfstoffe
DK1959991T3 (da) Terapeutisk vaccine
ATE450271T1 (de) Impfstoff
DK2049559T3 (da) Forbedrede HPV vacciner
DE602006021163D1 (de) Hämodialysator
DK1957528T3 (da) Nukleotid-vaccine
EP1917040A4 (en) POLYVALENT VACCINE
DK1928882T3 (da) (s)-n-methylnaltrexon
DE602006012066D1 (de) Daraus
CR10571A (es) Vacuna virica recombinante
DK2043682T3 (da) Influenzavaccine
DE602006019256D1 (de) Ophthalmologisches fotogerät
DK1942933T3 (da) Hundeinfluenzavacciner
DE602006006937D1 (de) Hosenträger
DK1848727T3 (da) Ibandronat polymorf b
BRPI0821034A2 (pt) Vírus influenza modificado
EP1856250A4 (en) NEW VACCINES LIVING VIRUSES
DE602006020309D1 (de) Filtriervorrichtung
DK1877549T3 (da) HIV-vaccine
ES1060333Y (es) Puntal telescopico
FI20050964A0 (fi) Virusvektori
NO20042454D0 (no) Novel fish virus